GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levels. (19th February 2020)
- Record Type:
- Journal Article
- Title:
- GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levels. (19th February 2020)
- Main Title:
- GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levels
- Authors:
- Carrillo-Gálvez, Ana Belén
Gálvez-Peisl, Sheyla
González-Correa, Juan Elías
Haro-Carrillo, Marina
Ayllón, Verónica
Carmona-Sáez, Pedro
Ramos-Mejía, Verónica
Galindo-Moreno, Pablo
Cara, Francisca E.
Granados-Principal, Sergio
Muñoz, Pilar
Martin, Francisco
Anderson, Per - Abstract:
- Abstract: Multipotent mesenchymal stromal cells (MSCs) have emerged as a promising cell therapy in regenerative medicine and for autoimmune/inflammatory diseases. However, a main hurdle for MSCs-based therapies is the loss of their proliferative potential in vitro. Here we report that glycoprotein A repetitions predominant (GARP) is required for the proliferation and survival of adipose-derived MSCs (ASCs) via its regulation of transforming growth factor-β (TGF-β) activation. Silencing of GARP in human ASCs increased their activation of TGF-β which augmented the levels of mitochondrial reactive oxygen species (mtROS), resulting in DNA damage, a block in proliferation and apoptosis. Inhibition of TGF-β signaling reduced the levels of mtROS and DNA damage and restored the ability of GARP −/low ASCs to proliferate. In contrast, overexpression of GARP in ASCs increased their proliferative capacity and rendered them more resistant to etoposide-induced DNA damage and apoptosis, in a TGF-β-dependent manner. In summary, our data show that the presence or absence of GARP on ASCs gives rise to distinct TGF-β responses with diametrically opposing effects on ASC proliferation and survival. : Abstract : Silencing of glycoprotein A repetitions predominant (GARP) in adipose-derived mesenchymal stromal cells (ASCs) increases the activation of transforming growth factor-β (TGF-β), resulting in mitochondrial reactive oxygen species-dependent DNA damage, inhibition of proliferation, andAbstract: Multipotent mesenchymal stromal cells (MSCs) have emerged as a promising cell therapy in regenerative medicine and for autoimmune/inflammatory diseases. However, a main hurdle for MSCs-based therapies is the loss of their proliferative potential in vitro. Here we report that glycoprotein A repetitions predominant (GARP) is required for the proliferation and survival of adipose-derived MSCs (ASCs) via its regulation of transforming growth factor-β (TGF-β) activation. Silencing of GARP in human ASCs increased their activation of TGF-β which augmented the levels of mitochondrial reactive oxygen species (mtROS), resulting in DNA damage, a block in proliferation and apoptosis. Inhibition of TGF-β signaling reduced the levels of mtROS and DNA damage and restored the ability of GARP −/low ASCs to proliferate. In contrast, overexpression of GARP in ASCs increased their proliferative capacity and rendered them more resistant to etoposide-induced DNA damage and apoptosis, in a TGF-β-dependent manner. In summary, our data show that the presence or absence of GARP on ASCs gives rise to distinct TGF-β responses with diametrically opposing effects on ASC proliferation and survival. : Abstract : Silencing of glycoprotein A repetitions predominant (GARP) in adipose-derived mesenchymal stromal cells (ASCs) increases the activation of transforming growth factor-β (TGF-β), resulting in mitochondrial reactive oxygen species-dependent DNA damage, inhibition of proliferation, and apoptosis. In contrast, overexpression of GARP induces a TGF-β response characterized by an increased resistance to DNA damage, increased proliferation, and a reduction in apoptosis. We show that GARP is critical in controlling TGF-β activation/signaling in ASCs during in vitro expansion. … (more)
- Is Part Of:
- Stem cells translational medicine. Volume 9:Number 5(2020)
- Journal:
- Stem cells translational medicine
- Issue:
- Volume 9:Number 5(2020)
- Issue Display:
- Volume 9, Issue 5 (2020)
- Year:
- 2020
- Volume:
- 9
- Issue:
- 5
- Issue Sort Value:
- 2020-0009-0005-0000
- Page Start:
- 636
- Page End:
- 650
- Publication Date:
- 2020-02-19
- Subjects:
- DNA damage -- mesenchymal stromal cells (MSCs) -- proliferation -- ROS -- TGF-β
Stem cells -- Periodicals
Regenerative medicine -- Periodicals
Periodicals
616.0277405 - Journal URLs:
- https://academic.oup.com/stcltm ↗
http://stemcellsjournals.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2157-6580/issues/ ↗
http://stemcellstm.alphamedpress.org/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/sctm.19-0372 ↗
- Languages:
- English
- ISSNs:
- 2157-6564
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25784.xml